Glioblastomas are highly aggressive brain tumors. Various pathways are involved in gliomagenesis, among which the Wingless (Wnt) signaling. Dickkopf protein-related protein 3 (Dkk-3) interacts with proteins of Wnt pathwayas inhibitor. The Wnt signaling contributes to activity of the claudins, that are critical components of tight junctions, whose expression was altered selectively in cerebral microvessels of glioblastoma. The aim of this study was to determine the role of Wnt pathways in the regulation of tumor growth, apoptosis process by targeting Dkk-3, tight junctions alteration involving claudin-5, suggesting possible therapeutic interactions involving Wnt/Toll-like receptors (TLRs) pathways.

TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas / Casili, Giovanna; Caffo, Maria; Campolo, Michela; Barresi, Valeria; Caruso, Gerardo; Cardali, Salvatore M; Lanza, Marika; Mallamace, Raffaella; Filippone, Alessia; Conti, Alfredo; Germanò, Antonino; Cuzzocrea, Salvatore; Esposito, Emanuela. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 9:101(2018), pp. 37564-37580. [10.18632/oncotarget.26500]

TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas

Conti, Alfredo;
2018

Abstract

Glioblastomas are highly aggressive brain tumors. Various pathways are involved in gliomagenesis, among which the Wingless (Wnt) signaling. Dickkopf protein-related protein 3 (Dkk-3) interacts with proteins of Wnt pathwayas inhibitor. The Wnt signaling contributes to activity of the claudins, that are critical components of tight junctions, whose expression was altered selectively in cerebral microvessels of glioblastoma. The aim of this study was to determine the role of Wnt pathways in the regulation of tumor growth, apoptosis process by targeting Dkk-3, tight junctions alteration involving claudin-5, suggesting possible therapeutic interactions involving Wnt/Toll-like receptors (TLRs) pathways.
2018
TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas / Casili, Giovanna; Caffo, Maria; Campolo, Michela; Barresi, Valeria; Caruso, Gerardo; Cardali, Salvatore M; Lanza, Marika; Mallamace, Raffaella; Filippone, Alessia; Conti, Alfredo; Germanò, Antonino; Cuzzocrea, Salvatore; Esposito, Emanuela. - In: ONCOTARGET. - ISSN 1949-2553. - STAMPA. - 9:101(2018), pp. 37564-37580. [10.18632/oncotarget.26500]
Casili, Giovanna; Caffo, Maria; Campolo, Michela; Barresi, Valeria; Caruso, Gerardo; Cardali, Salvatore M; Lanza, Marika; Mallamace, Raffaella; Filippone, Alessia; Conti, Alfredo; Germanò, Antonino; Cuzzocrea, Salvatore; Esposito, Emanuela
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/717772
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 11
  • ???jsp.display-item.citation.isi??? ND
social impact